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Abstract: 
Objective: to compare mean early postoperative pain score with and without use of port site & intraperitoneal bupivacaine in 
patients undergoing laparoscopic cholecystectomy under general anaesthesia. 
Study Design: Randomized controlled trial 
Setting: Department of Anaesthesia, Mayo Hospital Lahore  
Duration Of Study: from April 2012 to October 2012. 
Material & methods: 100 patients undergoing laparoscopic cholecystectomy were randomized in two groups (50 in each). 
Patients in study group(Group-A) received 20ml of intraperitoneal bupivacaine 0.25% and another 20ml of 0.25% bupivacaine 
for infiltration at port sites(5 ml at each). No intervention was done with patients in study group (Group-B). Assessment of early 
postoperative pain was done at 0, 2, 4 and 6 hours and two groups were compared. 
Results: Mean age in the study was calculated as 39.42 ± 4.27 years in group A and 37.88 ± 4.03 years in group B. Regarding 
gender distribution, 18 %( n=9) in Group-A and 28 %( n=14) in Group-B were males while 82 %( n=41) in Group-A and 72 %( 
n=36) in Group-B were females. Mean pain score was recorded at 0, 2, 4 and 6 hours postoperatively. Mean pain score at 0 
hour was 2.28 ± 0.99 in Group-A and 2.26 ± 0.98 in Group-B; p value was recorded as 0.920, which is insignificant. Similarly, 
there was no significant difference (p=0.068) between the groups regarding mean pain score at 2 hours which was recorded as 
4.580 ± 0.57 in group A and 4.808 ± 0.80 in Group B respectively. Mean pain score at 4 hour was 4.20 ± 0.80 in group A and 
5.86 ± 0.94 in group B (p=0.000) while at 6 hour it was 5.02 ± 0.91 in group A and 7.16 ± 1.36 in group B (p=0.000). 
Conclusion: We concluded that the use of port site and intraperitoneal bupivacaine is simple, safe, non-invasive and effective in 
decreasing early postoperative pain after laparoscopic cholecystectomy. 
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INTRODUCTION: 
Laparoscopic Cholecystectomy is a gold standard 
surgical procedure for symptomatic gall stones. The 
advantages of laparoscopic surgery include small 
cosmetic incision, lesser blood loss, reduced 
postoperative complications with early enteral intake. 
It allows rapid recovery, short hospital stay and early 
return to normal life and work activities. However, 
laparoscopic cholecystectomy is not a pain free 
technique. [1-3] Pain is more intense within 6 hours 
and greater analgesia is required in this early period 
postoperatively. Early postoperative pain relief and 
patient’s comfort is extremely important as it may 
delay early discharge and decrease cost effectiveness 
of this procedure. [4-8] 
  
Various analgesic interventions with different 
mechanisms have been adopted to provide early 
postoperative pain relief after laparoscopic 
cholecystectomy but definite conclusions are yet to 
be made. Control of post operative pain using 
NSAIDS and opioids come with the side effects like 
nausea, vomiting, sedation, respiratory depression, 
compromised renal function and increased risk of 
bleeding [9].  The idea of intraperitoneal 
administration of local anaesthetics is on horizon for 
controlling post operative pain after laproscopic 
cholecystectomy. It minimizes pain after 
laparoscopic surgery with safety, efficacy and 
minimal side effects. [2,6,7]  
 
Amongst local anaesthetics, bupivacaine is widely 
used and has been subject of many clinical trials with 
variable analgesic effect. Its half-life is 2.5 to 3.5 hrs 
and it provides analgesia for an average of 6 hrs. 
[4,5] 
 
Few studies are available regarding the use of port 
site & intraperitoneal bupivacaine for the control of 
pain after cholecytectomy. This study was designed 
to compare early postoperative pain following 
laparoscopic cholecystectomy with and without use 
of port site & intraperitoneal bupivacaine thereby 
providing the data regarding adequate analgesia after 
cholecytectomy in our local population. The aim was 
to find a better technique with reduced side effects 
for post operative analgesia, enhancing patient 
comfort with early hospital discharge and reduction 
of hospital expenses.  
 
METHODOLOGY: 
This Randomized controlled trial was carried out in 
Department of Anaesthesia, Mayo Hospital Lahore 
from April 2012 to October 2012. After approval 
from hospital ethical committee 100 patients 
undergoing laparoscopic cholecystectomy under 
general anaesthesia were included in the study (50 in 
each group) with 95% confidence level,80% power 
of test taking expected mean pain score (Mean ± SD) 
in study group(A) 6.08 ± 0.40 as compared to 8.44 ± 
0.51  in control group(B). Both male and female 
patients who were 18 years or above, belonging to 
ASA class I and II, scheduled to undergo laproscopic 
cholecystectomy under genral anaesthesia were 
included. Patients who were excluded from the study 
were those who had history of allergy to study 
medications, had previous abdominal surgery or 
choledocholithiasis and patients who could not 
properly understand visual analogue scale (VAS). 
Cases in which laparoscopic surgery was converted 
to open surgery or intraperitoneal drain wass placed 
at the end of surgery were also excluded.                      
 
Informed written consent was taken from all patients 
selected during pre-operative anaesthesia assessment 
carried out a day before surgery.  
 
All patients enrolled in the study were explained in 
detail about the use of visual analogue scale for 
evaluation of pain. On arrival in operation theatre, 
standard non-invasive monitoring was applied. All 
patients received injection ceftriaxone 1gm, 
nalbuphine 0.1 mg/kg, metoclopramide 10 mg 
intravenously as premedication. 
 
General anaesthesia was achieved by standard 
protocols using propofol (2mg/kg) for induction, 
suxamethonium (2mg/kg) to facilitate intubation, 
maintenance with oxygen and nitrous oxide at 
50%:50%, isoflurane at 1.5 MAC and muscle 
relaxation with atracurium 0.5mg/kg as loading dose 
and 0.1 mg/kg as maintenance dose repeated every 20 
mins. Pneumoperitoneum was produced by 
insufflation of CO2 at supraumblical port. 
Laparoscopic cholecystectomy was carried in reverse 
trendelenburg position using standard four ports 
technique by consultant surgeons with gas pressure 
maintained between 12-14 mm of Hg. Gall bladder 
was extracted through epigastric port. In the study 
group (Group A) 20 ml of 0.25% bupivacaine was 
instilled in the right subdiaphragmetic space & gall 
bladder bed in trendelenburg position and another 
20ml of 0.25% bupivacaine for local infiltration in 
the port sites (5 ml infiltration in each port). Normal 
saline was infiltrated in the patients in control group 
(Group B). The residual CO2 was carefully evacuated 
by manual compression of abdomen with open 
trocars at the end of the surgery. Reversal of muscle 
relaxation was done with neostigmine and atropine. 
Recovery and shifting to post operative ward was 
carried out according to standard protocols. Arrival 
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time in the postoperative ward was taken as zero hour 
postoperatively. 
 
Level of pain was assessed every 2 hourly for at 6 
hours postoperatively using the 10 point visual 
analogue scale (VAS). All patients demographic data, 
level of pain on VAS at 2 hrs interval postoperatively 
was recorded on a predesigned proforma and mean 
early postoperative pain score was calculated and 
compared in both groups.  
 
DATA ANALYSIS PROCEDURE: 
Data was analyzed using SPSS V 10. All quantitative 
variables like age, postoperative pain scores were 
quoted as Mean ± SD. Frequency and percentages 
were calculated for all qualitative variables like 
gender and comparison of mean pain score between 
groups was done using student’s t-test. The p ≤ 0·05 
was regarded as statistically significant. 
 
RESULTS: 
Age distribution of the patients showed that majority 
of the patients in both groups were between 41-50 
years i.e. 42%(n=21) in Group-A and 38%(n=19) in 
Group-B. 16%(n=8) in Group-A and 12%(n=6) in 
Group-B were between 18-30 years and 28%(n=14) 
in Group-A and 24%(n=12) in Group-B were 
between 31-40 years of age, while 14%(n=7) in 
Group-A and 26%(n=13) in Group-B had >50 years 
of age. Mean and SD was calculated as 39.42 ± 4.27 
and 37.88 ± 4.03 respectively. (Table No. 1) 
 
Gender distribution of the patients showed 18 %( 
n=9) in Group-A and 28 %( n=14) in Group-B were 
males while 82 %( n=41) in Group-A and 72 %( 
n=36) in Group-B were females. (Table No. 2) 
 
Mean pain score was recorded at 0, 2, 4 and 6 hours 
postoperatively. Mean pain score at 0 hour was 2.28 
± 0.99 in Group-A and 2.26 ± 0.98 in Group-B; p 
value was recorded as 0.90, which is insignificant. 
Similarly, there was no significant difference 
(p=0.068) between the groups regarding mean pain 
score at 2 hours which was recorded as 4.580 ± 0.57 
in group A and 4.808 ± 0.80 in Group B respectively. 
However, there was significant difference between 
groups regarding mean pain score at 4 and 6 hours. 
Mean pain score at 4 hour was 4.20 ± 0.80 in group 
A and 5.86 ± 0.94 in group B (p=0.000) while at 6 
hour it was 5.02 ± 0.91 in group A and 7.16 ± 1.36 in 
group B (p=0.000). (Table 3) 
 
 
TABLE No. 1: AGE DISTRIBUTION OF THE PATIENTS (n=100) 
Age(in years) 
Group-A 
(n=50) 
Group-B 
(n=50) 
No. of 
patients(n) 
% No. of 
patients(n) 
% 
18-30 8 16 6 12 
31-40 14 28 12 24 
41-50 21 42 19 38 
>50 7 14 13 26 
Total 50 100 50 100 
Mean and SD 39.43 ± 4.27 37.88 ± 4.03 
 
TABLE No. 2: GENDER DISTRIBUTION OF THE PATIENTS (n=100) 
Gender 
Group-A 
(n=50) 
Group-B 
(n=50) 
No. of 
patients(n) 
% No. of 
patients(n) 
% 
Male 9 18 14 28 
Female 41 82 36 72 
Total 50 100 50 100 
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TABLE No. 3: COMPARISON OF MEAN PAIN SCORE IN BOTH GROUPS (n=100) 
 
TIME INTERVAL 
(hours) 
 
GROUP-A 
(n=50) 
 
GROUP-B 
(n=50) 
 
p-VALUE 
0 hour 2.28 ± 0.99 2.26 ± 0.98 0.920(insignificant) 
2 hour 4.580 ± 0.57 4.808 ± 0.80 0.068(insignificant) 
4 hour 4.20 ± 0.80 5.86 ± 0.94 0.000(significant) 
6 hour 5.02 ± 0.91 7.16 ± 1.36 0.000(significant) 
 
DISCUSSION: 
Many benefits reported after laparoscopic surgery 
explain its increasing success in all surgical fields 
mostly general and gynecological surgery. 
Laparoscopic cholecystectomy (LC) has become a 
gold standard surgical procedure for removal of the 
gall bladder. [2,10] Some benefits of laparoscopic 
cholecystectomy include cosmetic scar, less blood 
loss and shorter hospital stay. Although laparoscopic 
cholecystectomy results in less postoperative pain 
and reduced analgesic consumption as compared with 
open cholecystectomy, it is not a pain free procedure. 
[11-13] 
  
The origin, intensity, character and duration of pain 
after laparoscopic cholecystectomy are variable and 
complex. According to some clinicians, primary 
source of somatic pain is surgical incision for the 
placement of trocars through abdominal wall. 
Visceral pain arises from insufflation of CO2 causing 
irritation of diaphragm & stretching of nerve endings 
and intraperitoneal dissection for removal of gall 
bladder from the liver bed. Finally, shoulder pain 
secondary to stretching of sub diaphragmatic fibers of 
the phrenic nerve as a result of CO2 
pneumoperitoneum is a frequent postoperative 
observation after laparoscopy (35% to 60%). [4,14-
18] During early hours after LC, more intense pain is 
experienced by the patients and greater analgesia is 
required. This pain can delay rapid recovery and 
ambulation thus decreasing cost effectiveness of the 
procedure. [19,20] 
 
Non-steroidal anti-inflammatory drugs (NSAID’s), 
opioids are usually used for post-operative pain 
management after laparoscopic cholecystectomy. The 
choice of various drugs, their undesirable effects, the 
timing, doses as well as different routes of their 
administration prevent introducing general 
recommendations in daily practice of a particular 
institution. [21] Moreover, treatment with NSAID’s 
and opioids for post laparoscopy pain yields 
controversial results. [8] 
 
Local anaesthetics are very important class of drug 
used for pain relief after laparoscopic 
cholecystectomy. They are safe, effective, and easy 
to administer and free of opioids side effects. 
Infiltration of port sites with local anaesthetics is 
effective and widely practiced. [22] Intraperitoneal 
injections of long acting local anaesthetics like 
bupivacaine, ropivacaine have been proposed to 
provide effective analgesia following laparoscopic 
cholecystectomy but they are not yet standardized. 
Several reports are available on the efficacy of 
intraperitoneal administration of local anaesthetic for 
analgesia after laparoscopic surgery. [3-8,20,23] The 
rationale of using intraperitoneal local 
anaesthetic(IPLA) in laparoscopic surgery is that 
local anaesthetics reduce nociception by inhibiting 
the release and actions of prostaglandins and 
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effecting nerve membrane associated proteins. [24] 
Chu PT [25], Sarac [16], in their studies reported 
reduction in intensity of pain after puncture sites 
were infiltrated with local anaesthetics where as Ure 
[26] did not find any reduction in pain using 
preincisional bupivacaine infiltration. Gupta et al. 
[19] used 20 ml of 0.5% bupivacaine 
intraperitoneally at the end of laparoscopic 
cholecystectomy. They reported reduced pain scores 
and decreased analgesic requirement as compared to 
control group in which 20 ml of 0.9% normal saline 
was used as placebo. 
 
We designed this randomized controlled trial 
considering that local scientific publications lack data 
regarding port site & intraperitoneal use of 
bupivacaine for pain relief after laparoscopic 
cholecystectomy and this prospective study can be 
used as local reference and encourage routine use of 
IPLA in our daily practice. More number of patients 
(100) is followed for 6 hours after laparoscopic 
cholecystectomy which is duration of maximum pain 
intensity. We used 40 ml of 0.25 % bupivacaine (100 
mg), 20 ml for intraperitoneal administration and 20 
ml for port sites infiltration (5 ml at each). This dose 
of bupivacaine is considered to be effective and also 
safe through these routes resulting in plasma 
concentration of bupivacaine below toxic level. 
[6,19] 
 
The results of our study revealed lower pain scores in 
both groups at 0 and 2 hour after laparoscopic 
cholecystectomy but comparison of mean pain score 
between two groups at 0 (p=0.920) and 2 (p=0.068) 
hours did not yield any significant difference. There 
was significantly lower mean pain scores (p=0.000) 
in study group as compared to control group at 4 and 
6 hours postoperatively. 
 
The findings of the study are in agreement with a 
recent study by Alam et al. [8] showing lower pain 
scores (6.08 ± 0.40) in early postoperative period 
after laparoscopic cholecystectomy with port site & 
intraperitoneal use of 0.25 % bupivacaine as 
compared to control group (8.44 ± 0.51) in which no 
bupivacaine is used. Maharjan SK and Shrestha S 
[20] studied the analgesic efficacy of intraperitoneal 
and periportal injection of bupivacaine following 
laparoscopic cholecystectomy and concluded that 
intraperitoneal and periportal injection of bupivacaine 
is effective in decreasing pain after laparoscopic 
cholecystectomy and resulted in reduced analgesic 
requirements. Two consecutive studies carried out by 
Johnson et al. [27] using intraperitoneal and 
periportal injection of bupivacaine after completion 
of surgery reported intraperitoneal use of bupivacaine 
an effective technique for decreasing postoperative 
pain after laparoscopic cholecystectomy. The 
addition of NSAID’s was having no additional 
benefit. 
 
The results of the study are in agreement with other 
above mentioned studies and also justify the 
hypothesis of the study that “mean early 
postoperative pain score following laparoscopic 
cholecystectomy is significantly less in study group 
(port site & intraperitoneal bupivacaine) as compared 
to control group”. 
 
Early post-operative pain experienced by the patients 
must be relieved if laparoscopic cholecystectomy is 
to become a routine ambulatory procedure. It 
increases the patients comfort and satisfaction. Use of 
both port site and intraperitoneal bupivacaine should 
be encouraged routinely as a part of multimodal 
analgesia thus helping to improve clinical outcome 
and cutting down hospital costs. 
 
CONCLUSION: 
We concluded that the use of port site and 
intraperitoneal bupivacaine is simple, safe, non-
invasive and effective in decreasing early 
postoperative pain after laparoscopic 
cholecystectomy and it should be carried out 
routinely thus benefiting all patients undergoing 
elective laparoscopic cholecystectomy. 
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